| 000 | 01659 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515025214.0 | ||
| 264 | 0 | _c20060804 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a1172-7047 | ||
| 024 | 7 |
_a10.2165/00023210-200620050-00005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBordier, Philippe | |
| 245 | 0 | 0 |
_aCardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer's disease. _h[electronic resource] |
| 260 |
_bCNS drugs _c2006 |
||
| 300 |
_a411-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCardiovascular System _xdrug effects |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aDonepezil |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aElectrocardiography _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndans _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPiperidines _xadverse effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 |
_aSyncope _xchemically induced |
| 700 | 1 | _aGarrigue, Stephane | |
| 700 | 1 | _aLanusse, Stephane | |
| 700 | 1 | _aMargaine, Julien | |
| 700 | 1 | _aRobert, Frederic | |
| 700 | 1 | _aGencel, Laurent | |
| 700 | 1 | _aLafitte, Alexia | |
| 773 | 0 |
_tCNS drugs _gvol. 20 _gno. 5 _gp. 411-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00023210-200620050-00005 _zAvailable from publisher's website |
| 999 |
_c16296690 _d16296690 |
||